COVID-19 Incidence Not Increased With Corticosteroid Injections
Incidence of COVID-19 lower for adults receiving image-guided corticosteroid injections for pain management
Incidence of COVID-19 lower for adults receiving image-guided corticosteroid injections for pain management
Sex-specific differences observed for efficacy of high-frequency, low-frequency spinal cord stimulation for chronic pain
Pain education, behavioral therapy delivered with physical therapy can help with physical function and pain intensity
Orphenadrine citrate ER tablet is indicated as an adjunct to rest, physical therapy and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions.
Evoke is a novel, closed-loop SCS system that instantaneously reads, records, and responds to evoked compound action potentials.
The Senza SCS System is a neuromodulation device designed to deliver electrical stimulation using implantable leads and a rechargeable, implantable pulse generator.
XT-150 is a locally injectable non-viral therapy expressing interleukin (IL)-10v, a proprietary modified variant of IL-10.
66 percent of patients randomly assigned to pain reprocessing therapy were pain-free after treatment compared with 20 percent in placebo group
This week we have news on pediatric influenza vaccine guidance; Moderna submit data for their COVID-19 booster dose; There’s new FDA warnings for some JAK inhibitors; Trudhesa nasal spray is approved; And the FDA places a clinical hold on a gene therapy for phenylketonuria.
Anecdotal reports suggest that naltrexone, an opioid antagonist, may alleviate symptoms associated with CRPS.